MASSDEVICE ON CALL — Medical device maker Edwards Lifesciences (NYSE:EW) hit a new 52-week low after lowering its 2013 outlook.
EW shares dropped briefly to $63.50 on Wednesday, April 24, a new low-watermark for the year, after the medical device giant lowered its sales expectations to the range of $2-2.1 billion for fiscal 2013.